Public Health Foundation Of India Medicines

Rediff.com » News » Public Health Foundation Of India Medicines

News for Public Health Foundation Of India Medicines

News
Business

Rediff's Wave Rider Retires!

After steering the Rediff mothership for close to 29 years, Ajit Balakrishnan, founder, chairman and CEO, did what few businessmen in this country do -- R-E-T-I-R-E. On August 2, 2024, we were......

'What Bigger Award One Can Hope For?'

'I did not take up research for any award.''What is more important is the medicine that I have developed.''This helps the patient recover and the family is happy that their relative has survived......

COVID-19: Are vegetarians more immune? Find out

Are vegans immune to COVID-19 ? There is no proof at the moment, says prominent health expert and president of the Public Health Foundation of India, Professor K Srinath Reddy. ......

'COVID-19 deaths could top 18,000 in India'

COVID-19 cases are expected to peak in early July in India, where deaths from the pandemic could top 18,000, an epidemiologist and a public health expert said. IMAGE: Family members and health......

'India must prep for community transmission of COVID-19'

India must gear up to face the possibility of community spread of the COVID-19, a prominent health expert said on Friday, cautioning that there could be more widespread transmission of the novel......

'Whatever we do, we have to make an impact'

'Professors can teach even when they are 90 because they don't lose their skill with words. Go deeper and there's spirituality in it,' Dr Swati Piramal tells Pavan Lall. Illustrations: Dominic......

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Almost each of these companies has a different technology to show for the effectiveness against microbes. In the last week of October, Asian Paints put out a half-page advertisement in some......

WHO works on cheaper R&D for India

Even as Indian pharmaceutical majors like Glenmark, Ranbaxy and Dr Reddys are hoping to come out with new drugs through in-house research and development (R&D), the World Health Organisation (WHO)......

India's economic reforms not enough: US official

Expressing concern over the investment and innovation environment in India, a top US trade official has said the recent set of economic reforms initiated by the country were not enough to return to......

Cipla gets Malaysian nod for AIDS drugs

In a trailblazing move, Malaysia has issued a compulsory licence to Mumbai-based Cipla for the supply of anti-retroviral medicines used in the treatment of Acquired Immuno Deficiency Syndrome. This......

Rediff News

Public Health Foundation Of India Medicines

News for Public Health Foundation Of India Medicines

Rediff's Wave Rider Retires!

'What Bigger Award One Can Hope For?'

COVID-19: Are vegetarians more immune? Find out

'COVID-19 deaths could top 18,000 in India'

'India must prep for community transmission of COVID-19'

'Whatever we do, we have to make an impact'

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

WHO works on cheaper R&D for India

India's economic reforms not enough: US official

Cipla gets Malaysian nod for AIDS drugs

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS